Disclosure Information

Financial disclosure information is current as of January 2015 and forward. Information is limited to financial relationships with commercial entities that have products in the field of hepatitis C. AASLD defines a direct financial relationship requiring disclosure as a compensated relationship with a company, by an individual, that should generate an IRS Form W2-1099.

Current Chairs

Marc G. Ghany, MD, MHSc* **

Personal Financial Relationships: None

Institutional Research: None

Updated: 10/24/2017

Arthur Y. Kim, MD

Personal Financial Relationships: None

Institutional Research: Dr. Kim was awarded research grants, paid to his institution, from AbbVie and Gilead Sciences, Inc.

Updated: 10/24/2017

Kristen M. Marks, MD

Personal Financial Relationships: None

Institutional Research: Dr. Marks was awarded research grants, paid to her institution, from Gilead Sciences, Inc, and Merk & Co, Inc.

Updated: 10/24/2017

Hugo E. Vargas, MD

Personal Financial Relationships: None

Institutional Research: Dr. Vargas was awarded research grants, paid to his institution, from AbbVie, Gilead Sciences, Inc, and Merck & Co, Inc.

Updated: 10/24/2017

Current Panel Members

Andrew I. Aronsohn, MD

Personal Financial Relationships: None

Institutional Research: None

Updated: 10/24/2017

Debika Bhattacharya, MD

Personal Financial Relationships: None

Institutional Research: None

Updated: 10/24/2017

Tina Broder, MSW, MPH

Personal Financial Relationships: None

Institutional Research: Ms. Broder's organization was awarded grants from AbbVie, Janssen, Gilead Sciences, Inc, Merck & Co, Inc, OraSure Technologies, Inc, Abbott, Quest Diagnostics, and Walgreens.

Updated: 10/24/2017

Oluwaseun O. Falade-Nwulia, MBBS, MPH

Personal Financial Relationships: None

Institutional Research: None

Updated: 10/24/2017

Jordan J. Feld, MD, MPH

Personal Financial Relationships: Dr. Feld serves as a scientific consultant to Abbvie, ContraVir Pharmaceuticals, Merck & Co Inc. and Gilead Sciences Inc.

Institutional Research: Dr. Feld was awarded research grants paid to his institution from Abbvie, Gilead Sciences, Inc, and Janssen.

Updated: 09/15/2017

Stuart C. Gordon, MD

Personal Financial Relationships: Dr. Gordon serves on scientific advisory boards for AbbVie, Bristol-Myers Squibb, Gilead Sciences, Inc, and Merck & Co, Inc.

Institutional Research: Dr. Gordon was awarded research grants, paid to his institution, from AbbVie, Bristol-Myers Squibb, Gilead Sciences, Inc, and Merck & Co, Inc.

Updated: 10/24/2017

Theo Heller, MD

Personal Financial Relationships: None

Institutional Research: None

Updated: 10/24/2017

Ravi Jhaveri, MD

Personal Financial Relationships: None

Institutional Research: None

Updated: 10/24/2017

Maureen M. Jonas, MD

Personal Financial Relationships: Dr. Jonas serves as a scientific consultant to AbbVie and Gilead Sciences, Inc.

Institutional Research: Dr. Jonas was awarded research grants, paid to her institution, from AbbVie, Bristol-Myers Squibb, Gilead Sciences, Inc, and Roche.

Updated: 10/24/2017

Jennifer J. Kiser, PharmD

Personal Financial Relationships: None

Institutional Research: Dr. Kiser was awarded research grants, paid to her institution, from Janssen Therapeutics, Inc.

Updated: 10/24/2017

Benjamin P. Linas, MD, MPH

Personal Financial Relationships: None

Institutional Research: None

Updated: 10/24/2017

Vincent Lo Re, MD, MSCE

Personal Financial Relationships: None

Institutional Research: None

Updated: 10/24/2017

Timothy R. Morgan, MD

Personal Financial Relationships: None

Institutional Research: Dr. Morgan was awarded research grants, paid to his institution, from AbbVie, Bristol-Myers Squibb, Genentech, Gilead Sciences, Inc, Merck & Co, Inc, and Roche.

Updated: 09/30/2015

Marion G. Peters, MD

Personal Financial Relationships: Dr. Peters' husband is an employee/officer/director and has stock options at Hoffman La Roche.

Institutional Research: None

Updated: 01/18/2017

K. Rajender Reddy, MD

Personal Financial Relationships: Dr. Reddy serves on advisory boards for AbbVie, Gilead Sciences, Inc, Merck & Co, Inc, and Vertex Pharmaceuticals, Inc.

Institutional Research: Dr. Reddy was awarded research grants, paid to his institution, from AbbVie, Bristol-Myers Squibb, Gilead Sciences, Inc, Janssen Therapeutics, Inc, and Merck.

Updated: 10/24/2017

Andrew Reynolds

Personal Financial Relationships: None

Institutional Research: Mr. Reynolds’s organization was awarded educational grants from AbbVie, Bristol-Myers Squibb, Genentech, Gilead Sciences, Inc, Janssen Therapeutics, Inc, Mercks & Co, Inc, OraSure Technologies, Inc, and Roche.

Updated: 10/14/2015

John D. Scott, MD, MSc, FIDSA

Personal Financial Relationships: None

Institutional Research: None

Updated: 10/24/2017

Gloria Searson, ACSW

Personal Financial Relationships: Ms. Searson serves on the Hepatitis Consumer Advisory Board.

Institutional Research: Ms. Searson's organization was awarded grants from AbbVie, Bristol-Myers Squibb, Janssen, Gilead Sciences, Inc, and Merck & Co, Inc.

Updated: 10/24/2017

Tracy Swan

Personal Financial Relationships: None

Institutional Research: None

Updated: 10/24/2017

Norah A. Terrault, MD

Personal Financial Relationships: Dr. Terrault serves on the medical affairs boards of Gilead Sciences, Inc (uncompensated) and Merck & Co, Inc. She serves on the marketing advisory boards of AbbVie (uncompensated) and on the scientific advisory board of Biotest. She also serves as a consultant to AbbVie, Biotest, CoCrystal Pharmaceuticals, and Gilead Sciences, Inc.

Institutional Research: Dr. Terrault was awarded research grants, paid to her institution, from AbbVie, Gilead Sciences, Inc, Merck & Co, Inc, and Vertex Pharmaceuticals, Inc.

Updated: 01/27/2017

Stacey B. Trooskin, MD, PhD

Personal Financial Relationships: Dr. Trooskin is a consultant for Gilead Sciences, Inc.

Institutional Research: Dr. Trooskin was awarded research grants, paid to her institution, from Gilead Sciences, Inc, and Gilead Sciences Foundation.

Updated: 10/24/2017

Elizabeth C. Verna, MD, MS

Personal Financial Relationships: Dr. Verna serves on an advisory board of Gilead Sciences, Inc.

Institutional Research: Dr. Verna was awarded research grants paid to her institution from Salix Pharmaceuticals.

Updated: 08/08/2017

John B. Wong, MD

Personal Financial Relationships: None

Institutional Research: None

Updated: 11/18/2016

Kim Workowski, MD

Personal Financial Relationships: None

Institutional Research: Dr. Workowkski was awarded research grants, paid to her institution, from AbbVie, Bristol-Myers Squibb, and Gilead Sciences, Inc.

Updated: 10/24/2017

David L. Wyles, MD

Personal Financial Relationships: Dr. Wyles served as a scientific consultant to Abbvie, Bristol-Myers Squibb, Gilead Sciences Inc., and Merck & Co, Inc (aforementioned all ceased as of November 2017).

Institutional Research: Dr. Wyles was awarded research grants, paid to his institution, from Abbvie, Bristol-Myers Squibb, Gilead Sciences Inc., and Merck & Co, Inc.

Updated: 01/16/2018